Efficacy of add-on deep transcranial magnetic stimulation in comorbid alcohol dependence and dysthymic disorder: Three case reports

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 15, Issue 1, 2013, Pages

  Rapinesi, Chiara ^a,b   Kotzalidis, Georgios D ^a   Serata, Daniele ^a,b   Del Casale, Antonio ^a   Bersani, Francesco S ^c   Solfanelli, Andrea ^a   Scatena, Paola ^b   Raccah, Ruggero N ^d   Brugnoli, Roberto ^a   Digiacomantonio, Vittorio ^b   Carbonetti, Paolo ^b   Fensore, Claudio ^b   Tatarelli, Roberto ^a   Angeletti, Gloria ^a   Ferracuti, Stefano ^a   Girardi, Paolo ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Villa Rosa Suore Hospitaliere of the Sacred Heart of Jesus ^*  (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d ATID Ltd Advanced Technology   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIPRAMINE; DIAZEPAM; DULOXETINE; MULTIVITAMIN; OLANZAPINE; TIAPRIDE; TRAZODONE;

ADOLESCENT; ADULT; ALCOHOL ABSTINENCE; ALCOHOL ABUSE; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANXIETY; ARTICLE; ATAXIA; CASE REPORT; CHILD ABUSE; COMORBIDITY; CONFABULATION; CONFUSION; DEEP BRAIN STIMULATOR; DEPRESSION; DETOXIFICATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DYSPHORIA; DYSTHYMIA; EVOKED MUSCLE RESPONSE; FEMALE; FOLLOW UP; HAMILTON SCALE; HOPELESSNESS; HUMAN; IRRITABILITY; LEFT HEMISPHERE; MALE; MOTOR CORTEX; NEUROLOGICAL EQUIPMENT; OBSESSIVE COMPULSIVE DRINKING SCALE; ORBITAL CORTEX; PANIC; PREFRONTAL CORTEX; PSYCHOLOGICAL RATING SCALE; PSYCHOSOCIAL WITHDRAWAL; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; TRANSCRANIAL MAGNETIC STIMULATION; WERNICKE ENCEPHALOPATHY;

EID: 84875482111     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088/PCC.12m01438     Document Type: Article

References (42)

1. World Health Organization. The ICD-10 Classification of Mental and Behavioral Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva, Switzerland: World Health Organization; 1992.
2. Drummond DC. Theories of drug craving, ancient and modern. Addiction. 2001;96(1):33-46. doi:10.1046/j.1360-0443.2001.961333.x
3. Park MS, Sohn JH, Suk JA, et al. Brain substrates of craving to alcohol cues in subjects with alcohol use disorder. Alcohol Alcohol. 2007;42(5):417-422.
4. Boggio PS, Sultani N, Fecteau S, et al. Prefrontal cortex modulation using transcranial DC stimulation reduces alcohol craving: a double-blind, sham-controlled study. Drug Alcohol Depend. 2008;92(1-3):55-60. doi:10.1016/j.drugalcdep.2007.06.011
5. Olbrich HM, Valerius G, Paris C, et al. Brain activation during craving for alcohol measured by positron emission tomography. Aust N Z J Psychiatry. 2006;40(2):171-178. doi:10.1080/j.1440-1614.2006.01765.x
6. Goetzel RZ, Hawkins K, Ozminkowski RJ, et al. The health and productivity cost burden of the "top 10" physical and mental health conditions affecting six large US employers in 1999. JOccup Environ Med. 2003;45(1):5-14. doi:10.1097/00043764-200301000-00007
7. Hoff RA, Rosenheck RA. The cost of treating substance abuse patients with and without comorbid psychiatric disorders. Psychiatr Serv. 1999;50(10):1309-1315.
8. Westermeyer J, Eames SL, Nugent S. Comorbid dysthymia and substance disorder: treatment history and cost. Am J Psychiatry. 1998;155(11):1556-1560.
9. Weissman MM, Leaf PJ, Bruce ML, et al. The epidemiology of dysthymia in five communities: rates, risks, comorbidity, and treatment. Am J Psychiatry. 1988;145(7):815-819.
10. Iovieno N, Tedeschini E, Bentley KH, et al. Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials. JClin Psychiatry. 2011;72(8):1144-1151. doi:10.4088/JCP.10m06217
11. O'Brien CP. Anticraving medications for relapse prevention: a possible new class of psychoactive medications. Am J Psychiatry. 2005;162(8):1423-1431. doi:10.1176/appi.ajp.162.8.1423
12. Mishra BR, Nizamie SH, Das B, et al. Efficacy of repetitive transcranial magnetic stimulation in alcohol dependence: a sham-controlled study. Addiction. 2010;105(1):49-55. doi:10.1111/j.1360-0443.2009.02777.x
13. Politi E, Fauci E, Santoro A, et al. Daily sessions of transcranial magnetic stimulation to the left prefrontal cortex gradually reduce cocaine craving. Am J Addict. 2008;17(4):345-346. doi:10.1080/10550490802139283
14. Lang N, Hasan A, Sueske E, et al. Cortical hypoexcitability in chronic smokers? a transcranial magnetic stimulation study. Neuropsychopharmacology. 2008;33(10):2517-2523. doi:10.1038/sj.npp.1301645
15. Amiaz R, Levy D, Vainiger D, et al. Repeated high-frequency transcranial magnetic stimulation over the dorsolateral prefrontal cortex reduces cigarette craving and consumption. Addiction. 2009;104(4):653-660. doi:10.1111/j.1360-0443.2008.02448.x
16. Barr MS, Fitzgerald PB, Farzan F, et al. Transcranial magnetic stimulation to understand the pathophysiology and treatment of substance use disorders. Curr Drug Abuse Rev. 2008;1(3):328-339. doi:10.2174/1874473710801030328
17. Feil J, Zangen A. Brain stimulation in the study and treatment of addiction. Neurosci Biobehav Rev. 2010;34(4):559-574. doi:10.1016/j.neubiorev.2009.11.006
18. Kobayashi M, Pascual-Leone A. Transcranial magnetic stimulation in neurology. Lancet Neurol. 2003;2(3):145-156. doi:10.1016/S1474-4422(03)00321-1
19. Staroverov AT, Vil'yanov VB, Raigorodskii YM, et al. Transcranial magnetotherapy in the complex treatment of affective disorders in patients with alcoholism. Neurosci Behav Physiol. 2009;39(5):507-511. doi:10.1007/s11055-009-9149-z
20. Staroverov AT, Zhukov OB, Raigorodskii YM. Efficacy of transcranial magnetotherapy in the complex treatment of alcohol withdrawal syndrome. Neurosci Behav Physiol. 2009;39(9):891-895. doi:10.1007/s11055-009-9206-7
21. De Ridder D, Vanneste S, Kovacs S, et al. Transient alcohol craving suppression by rTMS of dorsal anterior cingulate: an fMRI and LORETA EEG study. Neurosci Lett. 2011;496(1):5-10. doi:10.1016/j.neulet.2011.03.074
22. Herremans SC, Baeken C, Vanderbruggen N, et al. No influence of one right-sided prefrontal HF-rTMS session on alcohol craving in recently detoxified alcohol-dependent patients: results of a naturalistic study. Drug Alcohol Depend. 2012;120(1-3):209-213. doi:10.1016/j.drugalcdep.2011.07.021
23. Staroverov AT, Zhukov OB, Raǐgorodskǐ IuM. Effectiveness of transcranial magnetic therapy in the complex treatment of alcohol abstinent syndrome [Russian]. Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(9):57-61.
24. Levkovitz Y, Harel EV, Roth Y, et al. Deep transcranial magnetic stimulation over the prefrontal cortex: evaluation of antidepressant and cognitive effects in depressive patients. Brain Stimulat. 2009;2(4):188-200. doi:10.1016/j.brs.2009.08.002
25. Rosenberg O, Shoenfeld N, Zangen A, et al. Deep TMS in a resistant major depressive disorder: a brief report. Depress Anxiety. 2010a;27(5):465-469. doi:10.1002/da.20689
26. Rosenberg O, Zangen A, Stryjer R, et al. Response to deep TMS in depressive patients with previous electroconvulsive treatment. Brain Stimulat. 2010b;3(4):211-217. doi:10.1016/j.brs.2009.12.001
27. Rosenberg O, Isserles M, Levkovitz Y, et al. Effectiveness of a second deep TMS in depression: a brief report. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(4):1041-1044. doi:10.1016/j.pnpbp.2011.02.015
28. Isserles M, Rosenberg O, Dannon P, et al. Cognitive-emotional reactivation during deep transcranial magnetic stimulation over the prefrontal cortex of depressive patients affects antidepressant outcome. JAffect Disord. 2011;128(3):235-242. doi:10.1016/j.jad.2010.06.038
29. Harel EV, Zangen A, Roth Y, et al. H-coil repetitive transcranial magnetic stimulation for the treatment of bipolar depression: an add-on, safety and feasibility study. World J Biol Psychiatry. 2011;12(2):119-126. doi:10.3109/15622975.2010.510893
30. Bersani FS, Girardi N, Sanna L, et al. Deep transcranial magnetic stimulation for treatment-resistant bipolar depression: a case report of acute and maintenance efficacy. [published online ahead of print July 24, 2012]. Neurocase.d
31. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. New York, NY: Biometrics Research, New York State Psychiatric Institute; 2002: A1-A46.
32. First MB, Gibbon M, Spitzer RL, et al. Structured Clinical Interview for DSM-IV Axis II Personality Disorders, (SCID-II). Washington, DC: American Psychiatric Press, Inc, 1997.
33. Hamilton M. A rating scale for depression. JNeurol Neurosurg Psychiatry. 1960;23(1):56-62. doi:10.1136/jnnp.23.1.56
34. Anton RF, Moak DH, Latham P. The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior. Alcohol Clin Exp Res. 1995;19(1):92-99. doi:10.1111/j.1530-0277.1995.tb01475.x
35. Roth Y, Amir A, Levkovitz Y, et al. Three-dimensional distribution of the electric field induced in the brain by transcranial magnetic stimulation using figure-8 and deep H-coils. JClin Neurophysiol. 2007;24(1):31-38. doi:10.1097/WNP.0b013e31802fa393
36. Bates ME, Bowden SC, Barry D. Neurocognitive impairment associated with alcohol use disorders: implications for treatment. Exp Clin Psychopharmacol. 2002;10(3):193-212. doi:10.1037/1064-1297.10.3.193
37. Bazargan-Hejazi S, Bazargan M, Hardin E, et al. Alcohol use and adherence to prescribed therapy among under-served Latino and African-American patients using emergency department services. Ethn Dis. 2005;15(2):267-275.
38. Harwood R, Fountain D, Livermore G. The Economic Costs of Alcohol and Drug Abuse in the United States, 1992. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism and National Institute on Drug Abuse; 1998.
39. Hasin DS, Goodwin RD, Stinson FS, et al. Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry. 2005;62(10):1097-1106. doi:10.1001/archpsyc.62.10.1097
40. Grant BF, Stinson FS, Dawson DA, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61(8):807-816. doi:10.1001/archpsyc.61.8.807
41. Flensborg-Madsen T. Alcohol use disorders and depression-the chicken or the egg? Addiction. 2011;106(5):916-918. doi:10.1111/j.1360-0443.2011.03406.x
42. Fergusson DM, Boden JM, Horwood LJ. Tests of causal links between alcohol abuse or dependence and major depression. Arch Gen Psychiatry. 2009;66(3):260-266. doi:10.1001/archgenpsychiatry.2008.543